Defining Treatment Response, Remission, Relapse, and Recovery in First-Episode Psychosis: A Survey among Korean Experts

키워드

참고문헌 (98)

1. Patel KR, "Schizophrenia : overview and treatment options", P T, 39, pp.638~645 (2014)
2. Leucht S, "Defining ‘response’in antipsychotic drug trials : recommendations for the use of scale-derived cutoffs", Neuropsychopharmacology, 32, pp.1903~1910 (2007)
3. Leucht S, "Measurements of response, remission, and recovery in schizophrenia and examples for their clinical application", J Clin Psychiatry, 75(Suppl 1), pp.8~14 (2014)
4. Lally J, "Remission and recovery from first-episode psychosis in adults : systematic review and meta-analysis of long-term outcome studies", Br J Psychiatry, 211, pp.350~358 (2017)
5. San L, "Towards a pragmatic and operational definition of relapse in schizophrenia:A Delphi consensus approach", Int J Psychiatry Clin Pract, 19, pp.90~98 (2015)
6. Kay SR, "The positive and negative syndrome scale(PANSS)for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
7. Overall JE, "The Brief Psychiatric Rating Scale(BPRS) : recent developments in ascertainment and scaling", Psychopharmacol Bull, 24, pp.97~99 (1988)
8. Andreasen NC, "The Scale for the Assessment of Negative Symptoms(SANS) : conceptual and theoretical foundations", Br J Psychiatry Suppl, (7), pp.49~58 (1989)
9. National Institute of Mental Health(NIMH), "Clinical global impressions", Psychopharmacol Bull, 21, pp.839~843 (1985)
10. Leucht S, "Clinical implications of Brief Psychiatric Rating Scale scores", Br J Psychiatry, 187, pp.366~371 (2005)
11. Correll CU, "Quantifying clinical relevance in the treatment of schizophrenia", Clin Ther, 33, pp.B16~B39 (2011)
12. Kinon BJ, "Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia", Schizophr Res, 102, pp.230~240 (2008)
13. Correll CU, "Early prediction of antipsychotic response in schizophrenia", Am J Psychiatry, 160, pp.2063~2065 (2003)
14. Loebel A, "Treatment of early non-response in patients with schizophrenia : assessing the efficacy of antipsychotic dose escalation", BMC Psychiatry, 15, pp.271~ (2015)
15. Gallego JA, "Time to treatment response in first-episode schizophrenia:should acute treatment trials last several months?", J Clin Psychiatry, 72, pp.1691~1696 (2011)
16. Emsley R, "Time course for antipsychotic treatment response in first-episode schizophrenia", Am J Psychiatry, 163, pp.743~745 (2006)
17. Samara MT, "How many patients with schizophrenia do not respond to antipsychotic drugs in the short term? An analysis based on individual patient data from randomized controlled trials", Schizophr Bull, 45, pp.639~646 (2019)
18. Lieberman J, "Time course and biologic correlates of treatment response in first-episode schizophrenia", Arch Gen Psychiatry, 50, pp.369~376 (1993)
19. Wunderink L, "Guided discontinuation versus maintenance treatment in remitted first-episode psychosis : relapse rates and functional outcome", J Clin Psychiatry, 68, pp.654~661 (2007)
20. Perkins D, "Predictors of antipsychotic treatment response in patients with firstepisode schizophrenia, schizoaffective and schizophreniform disorders", Br J Psychiatry, 185, pp.18~24 (2004)
21. Eaton WW, "Remission and relapse in schizophrenia : the Madras Longitudinal Study", J Nerv Ment Dis, 186, pp.357~363 (1998)
22. Ho BC, "Untreated initial psychosis : its relation to quality of life and symptom remission in first-episode schizophrenia", Am J Psychiatry, 157, pp.808~815 (2000)
23. Andreasen NC, "Remission in schizophrenia : proposed criteria and rationale for consensus", Am J Psychiatry, 162, pp.441~449 (2005)
24. Menezes NM, "A systematic review of longitudinal outcome studies of first-episode psychosis", Psychol Med, 36, pp.1349~1362 (2006)
25. AlAqeel B, "Remission in schizophrenia : critical and systematic review", Harv Rev Psychiatry, 20, pp.281~297 (2012)
26. 정영철, "정신분열병의 치료 반응, 관해 및 회복: 정의와 기준", 대한정신약물학회지, 17(1), pp.5~12 (2006), 대한정신약물학회
27. Leucht S, "Measurement-based psychiatry : definitions of response, remission, stability, and relapse in schizophrenia", J Clin Psychiatry, 67, pp.1813~1814 (2006)
28. Obermeier M, "Is the PANSS used correctly? a systematic review", BMC Psychiatry, 11, pp.113~ (2011)
29. McCue RE, "Comparative effectiveness of second-generation antipsychotics and haloperidol in acute schizophrenia", Br J Psychiatry, 189, pp.433~440 (2006)
30. Lieberman JA, "Effectiveness of antipsychotic drugs in patients with chronic schizophrenia", N Engl J Med, 353, pp.1209~1223 (2005)
31. Robinson DG, "Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder", Am J Psychiatry, 156, pp.544~549 (1999)
32. Emsley RA, "Partial response to antipsychotic treatment : the patient with enduring symptoms", J Clin Psychiatry, 60(Suppl 23), pp.10~13 (1999)
33. Chakos M, "Effectiveness of second-generation antipsychotics in patients with treatmentresistant schizophrenia : a review and meta-analysis of randomized trials", Am J Psychiatry, 158, pp.518~526 (2001)
34. 정석훈, "리스페리돈 장기 지속형 주사제의 효용과 안정성：12주 다기관 경구 항정신병약물로부터 교체연구", 대한정신약물학회지, 16(2), pp.109~120 (2005), 대한정신약물학회
35. Green AI, "First episode schizophrenia-related psychosis and substance use disorders : acute response to olanzapine and haloperidol", Schizophr Res, 66, pp.125~135 (2004)
36. Emsley RA, "Risperidone in the treatment of first-episode psychotic patients : a double-blind multicenter study. Risperidone Working Group", Schizophr Bull, 25, pp.721~729 (1999)
37. Gasquet I, "Patient satisfaction with psychotropic drugs : sensitivity to change and relationship to clinical status, quality-of-life, compliance and effectiveness of treatment. Results from a nation-wide 6-month prospective study", Eur Psychiatry, 21, pp.531~538 (2006)
38. Beasley CM, Jr., "Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial", Eur Neuropsychopharmacol, 7, pp.125~137 (1997)
39. Breier A, "Clozapine treatment of outpatients with schizophrenia : outcome and long-term response patterns. 1993", Psychiatr Serv, 51, pp.1249~1253 (2000)
40. Kane J, "Clozapine for the treatmentresistant schizophrenic. A double-blind comparison with chlorpromazine", Arch Gen Psychiatry, 45, pp.789~796 (1988)
41. Amminger GP, "Premorbid adjustment and remission of positive symptoms in first-episode psychosis", Eur Child Adolesc Psychiatry, 6, pp.212~218 (1997)
42. 정석훈, "정신분열병 임상 연구에서의 증상 관해 기준과 관해율", 대한정신약물학회지, 18(4), pp.231~239 (2007), 대한정신약물학회
43. Stauffer VL, "Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with firstepisode psychosis", Psychiatry Res, 187, pp.42~48 (2011)
44. Leucht S, "Definitions of response and remission in schizophrenia: recommendations for their use and their presentation", Acta Psychiatr Scand Suppl, (438), pp.7~14 (2009)
45. Curtis CE, "Saccadic disinhibition in patients with acute and remitted schizophrenia and their first-degree biological relatives", Am J Psychiatry, 158, pp.100~106 (2001)
46. Yen CF, "Comparison of insight in patients with schizophrenia and bipolar disorder in remission", J Nerv Ment Dis, 190, pp.847~849 (2002)
47. Loebel AD, "Duration of psychosis and outcome in first-episode schizophrenia", Am J Psychiatry, 149, pp.1183~1188 (1992)
48. Larsen TK, "Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis", Schizophr Res, 45, pp.1~9 (2000)
49. Malla AK, "Status of patients with first-episode psychosis after one year of phase-specific community-oriented treatment", Psychiatr Serv, 53, pp.458~463 (2002)
50. Mayerhoff DI, "The deficit state in first-episode schizophrenia", Am J Psychiatry, 151, pp.1417~1422 (1994)
51. Addington J, "Symptom outcome 1 year after admission to an early psychosis program", Can J Psychiatry, 48, pp.204~207 (2003)
52. Auslander LA, "Sustained remission of schizophrenia among community-dwelling older outpatients", Am J Psychiatry, 161, pp.1490~1493 (2004)
53. Wiersma D, "Natural course of schizophrenic disorders : a 15-year followup of a Dutch incidence cohort", Schizophr Bull, 24, pp.75~85 (1998)
54. Huber G, "Longitudinal studies of schizophrenic patients", Schizophr Bull, 6, pp.592~605 (1980)
55. Singh SP, "Acute and transient psychotic disorders : precursors, epidemiology, course and outcome", Br J Psychiatry, 185, pp.452~459 (2004)
56. van Os J, "Standardized remission criteria in schizophrenia", Acta Psychiatr Scand, 113, pp.91~95 (2006)
57. Simonsen E, "Clinical epidemiologic first-episode psychosis : 1-year outcome and predictors", Acta Psychiatr Scand, 116, pp.54~61 (2007)
58. Bobes J, "Recovery from schizophrenia : results from a 1-year follow-up observational study of patients in symptomatic remission", Schizophr Res, 115, pp.58~66 (2009)
59. Robinson D, "Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder", Arch Gen Psychiatry, 56, pp.241~247 (1999)
60. Fleischhacker WW, "The European First Episode Schizophrenia Trial (EUFEST): rationale and design of the trial", Schizophr Res, 78, pp.147~156 (2005)
61. Schooler N, "Risperidone and haloperidol in first-episode psychosis : a longterm randomized trial", Am J Psychiatry, 162, pp.947~953 (2005)
62. Csernansky JG, "A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia", N Engl J Med, 346, pp.16~22 (2002)
63. Arato M, "A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg", day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study, 2002, pp.17, 207~215
64. Chrzanowski WK, "Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine", Psychopharmacology(Berl), 189, pp.259~266 (2006)
65. Lee SH, "Effectiveness of a psychosocial intervention for relapse prevention in patients with schizophrenia receiving risperidone via long-acting injection", Psychiatry Res, 175, pp.195~199 (2010)
66. Altamura AC, "Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia : a retrospective study", Schizophr Res, 52, pp.29~36 (2001)
67. The Scottish first episode schizophrenia study, "VIII. Five-year followup:clinical and psychosocial findings. The Scottish Schizophrenia Research Group", Br J Psychiatry, 161, pp.496~500 (1992)
68. Bhugra D, "First-contact incidence rates of schizophrenia in Trinidad and one-year follow-up", Br J Psychiatry, 169, pp.587~592 (1996)
69. Marneros A, "What is schizophrenic in acute and transient psychotic disorder?", Schizophr Bull, 29, pp.311~323 (2003)
70. Jager MDM, "Course and outcome of first-admitted patients with acute and transient psychotic disorders (ICD-10:F23). Focus on relapses and social adjustment", Eur Arch Psychiatry Clin Neurosci, 253, pp.209~215 (2003)
71. Gaebel W, "Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia", Eur Arch Psychiatry Clin Neurosci, 254, pp.129~140 (2004)
72. Kramer M, "Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia : a randomized, doubleblind, placebo-controlled study", J Clin Psychopharmacol, 27, pp.6~14 (2007)
73. Pigott TA, "Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia : a placebo-controlled 26-week study", J Clin Psychiatry, 64, pp.1048~1056 (2003)
74. Liberman RP, "Operational criteria and factors related to recovery from schizophrenia", Int Rev Psychiatry, 14, pp.256~272 (2002)
75. Lauronen E, "Recovery from schizophrenic psychoses within the northern Finland 1966 Birth Cohort", J Clin Psychiatry, 66, pp.375~383 (2005)
76. Torgalsboen AK, "Full recovery from schizophrenia : the prognostic role of premorbid adjustment, symptoms at first admission, precipitating events and gender", Psychiatry Res, 88, pp.143~152 (1999)
77. Robinson DG, "Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder", Am J Psychiatry, 161, pp.473~479 (2004)
78. Harrison G, "Recovery from psychotic illness : a 15-and 25-year international followup study", Br J Psychiatry, 178, pp.506~517 (2001)
79. Onken SJ, "An analysis of the definitions and elements of recovery : a review of the literature", Psychiatr Rehabil J, 31, pp.9~22 (2007)
80. Harrow M, "Do patients with schizophrenia ever show periods of recovery? A 15-year multi-followup study", Schizophr Bull, 31, pp.723~734 (2005)
81. Drake RE, "Tenyear recovery outcomes for clients with co-occurring schizophrenia and substance use disorders", Schizophr Bull, 32, pp.464~473 (2006)
82. Liberman RP, "Recovery from schizophrenia : a concept in search of research", Psychiatr Serv, 56, pp.735~742 (2005)
83. Hall RC, "Global assessment of functioning. A modified scale", Psychosomatics, 36, pp.267~275 (1995)
84. Goldman HH, "Revising axis V for DSM-IV : a review of measures of social functioning", Am J Psychiatry, 149, pp.1148~1156 (1992)
85. Shafer A, "Meta-analysis of the positive and Negative Syndrome Scale(PANSS)factor structure", J Psychiatr Res, 115, pp.113~120 (2019)
86. Lieberman JA, "Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine", Neuropsychopharmacology, 28, pp.995~1003 (2003)
87. Emsley R, "The nature of relapse in schizophrenia", BMC Psychiatry, 13, pp.50~ (2013)
88. Leucht S, "Relapse prevention in schizophrenia with new-generation antipsychotics : a systematic review and exploratory meta-analysis of randomized, controlled trials", Am J Psychiatry, 160, pp.1209~1222 (2003)
89. Olivares JM, "Definitions and drivers of relapse in patients with schizophrenia : a systematic literature review", Ann Gen Psychiatry, 12, pp.32~ (2013)
90. McGlashan TH, "The Chestnut Lodge follow-up study. II. Long-term outcome of schizophrenia and the affective disorders", Arch Gen Psychiatry, 41, pp.586~601 (1984)
91. Link BG, "Problems in measuring role strains and social functioning in relation to psychological symptoms", J Health Soc Behav, 31, pp.354~369 (1990)
92. Bellack AS, "Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMHsponsored workshop", Schizophr Bull, 33, pp.805~822 (2007)
93. Wunderink L, "Clinical recovery in first-episode psychosis", Schizophr Bull, 35, pp.362~369 (2009)
94. Mayoral-van Son J, "Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals : a 3-year naturalistic follow-up study", J Clin Psychiatry, 77, pp.492~500 (2016)
95. Wyatt RJ, "First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment", Br J Psychiatry Suppl, 172, pp.77~83 (1998)
96. 김성완, "Design and Methodology of the Korean Early Psychosis Cohort Study", PSYCHIATRY INVESTIGATION, 14(1), pp.93~99 (2017), 대한신경정신의학회[DOI]
97. Modestin J, "Long-term course of schizophrenic illness : Bleuler’s study reconsidered", Am J Psychiatry, 160, pp.2202~2208 (2003)
98. Jaaskelainen E, "A systematic review and meta-analysis of recovery in schizophrenia", Schizophr Bull, 39, pp.1296~1306 (2013)

관련 논문AI추천